Price
$121.99+1.94%Social Signal Score
Analyst Ratings
27 analysts52-week range
- Last close
- $121.99
- Off 52w high
- -4.1%
- 200-day average
- $106.86
- vs 200-day
- +14.2%
Revenue
$1.61B+72.07%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Mark J. Tarr
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 29,875
- Beta
- 0.60
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 3.67
Financials
Revenue
$1.61B+72.1%Net Income
$149.90M+129.6%EBITDA
$385.70M+86.4%Free Cash Flow
$127.50M+186.5%EPS (diluted)
$1.50+120.6%Shares Outstanding (diluted)
99.70M+0.5%Operating Expenses
$59.90MCash & Debt
$76.20MReturn of Capital
$76.60MRevenue by Segment (annual)
$5.94BDividend per Share
$0.21Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.94B | $566.20M | $5.62 |
| 2024 | $5.37B | $455.70M | $4.53 |
| 2023 | $4.80B | $352.00M | $3.54 |
| 2022 | $4.35B | $271.00M | $2.72 |
| 2021 | $4.01B | $412.20M | $4.15 |
| 2020 | $3.57B | $284.20M | $2.87 |
| 2019 | $4.61B | $358.70M | $3.65 |
| 2018 | $4.28B | $292.30M | $2.99 |
| 2017 | $3.91B | $271.10M | $2.73 |
| 2016 | $3.64B | $247.60M | $2.77 |
| 2015 | $3.12B | $183.10M | $2.02 |
| 2014 | $2.37B | $222.00M | $2.46 |
| 2013 | $2.25B | $323.60M | $2.58 |
| 2012 | $2.13B | $185.00M | $1.67 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from EHC's reported EPS growth of 9.8% a year over 13 years.
- EPS in 5 years
- $8.99
- Implied price
- $170.83
- Return from $130.80
- 5.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $84.93 — -35.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 13 | 16 | 19 | 22 | 25 |
|---|---|---|---|---|---|
| -0.2% | -11.1% | -7.4% | -4.1% | -1.3% | 1.3% |
| 4.8% | -6.7% | -2.7% | 0.7% | 3.7% | 6.4% |
| 9.8% | -2.2% | 1.9% | 5.5% | 8.6% | 11.4% |
| 14.8% | 2.2% | 6.6% | 10.3% | 13.6% | 16.5% |
| 19.8% | 6.7% | 11.2% | 15.1% | 18.5% | 21.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
57-63.04%Social Signal Score
Mentions (44)
- Newszacks.com·5d ago·Neutral
Encompass Health Stock Rallies 34% YTD: Is There More Upside Ahead? Encompass Health Corporation EHC has soared 33.9% year to date, edging past the industry's 32% gain and comfortably beating the S&P 500's 9.4% rise. Consistent operating growth, improving profitability outlook, strategic capacity expansion and shareholder-friendly initiatives have helped keep buyers interested.
View source ↗ - Newszacks.com·20d ago·Neutral
Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know Does Encompass Health (EHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·20d ago·Positive
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run? Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newsmarketbeat.com·23d ago·Neutral
Encompass Health Q3 Earnings Call Highlights Encompass Health NYSE: EHC raised its full-year 2026 outlook after reporting third-quarter revenue growth of 8.9%, adjusted EBITDA growth of 15.5% and adjusted earnings-per-share growth of 23.6%, driven by higher discharges, increased patient acuity and revenue per discharge.
View source ↗ - Newsseekingalpha.com·24d ago·Neutral
Encompass Health Corporation (EHC) Q3 2026 Earnings Call Transcript Encompass Health Corporation ( EHC ) Q3 2026 Earnings Call October 29, 2026 10:00 AM EDT Company Participants Mark Miller - Senior Vice President of Investor Relations & Strategic Planning Mark Tarr - CEO, President & Director Douglas Coltharp - Executive VP & CFO Patrick Tuer - Executive VP & COO Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Di…
View source ↗ - Newszacks.com·25d ago·Neutral
Encompass Health (EHC) Reports Q3 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
View source ↗ - Newszacks.com·25d ago·Positive
Encompass Health (EHC) Q3 Earnings and Revenues Top Estimates Encompass Health (EHC) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.23 per share a year ago.
View source ↗ - Newsprnewswire.com·25d ago·Neutral
Encompass Health reports results for third quarter 2026 Increases full-year guidance BIRMINGHAM, Ala., Oct. 28, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2026.
View source ↗ - Newsprnewswire.com·27d ago·Neutral
Encompass Health expands in Fort Bend County, Texas, with second small-format hospital in Houston area BIRMINGHAM, Ala. and RICHMOND, Texas, Oct. 26, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to expand inpatient rehabilitation capacity in Fort Bend County through a new project in Richmond, Texas.
View source ↗ - Newszacks.com·27d ago·Positive
Here's Why Encompass Health (EHC) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newszacks.com·30d ago·Positive
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy? Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newsprnewswire.com·31d ago·Neutral
Encompass Health Rehabilitation Hospital of Westover Hills now open in Texas BIRMINGHAM, Ala. and SAN ANTONIO, Oct. 22, 2026 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Westover Hills in San Antonio, Texas.
View source ↗ - Newsprnewswire.com·31d ago·Negative
Encompass Health declares dividend on common stock BIRMINGHAM, Ala., Oct. 22, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced that its board of directors declared a quarterly cash dividend on its common stock of $0.21 per share, payable on Jan. 15, 2027, to holders of record on Jan. 4, 2027.
View source ↗ - Newsprnewswire.com·34d ago·Neutral
Newsweek names Encompass Health America's Most Awarded Leader in Inpatient Rehabilitation for seventh consecutive year BIRMINGHAM, Ala., Oct. 19, 2026 /PRNewswire/ -- Encompass Health today announced it has been named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh consecutive year.
View source ↗ - Newszacks.com·37d ago·Positive
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue? Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newszacks.com·46d ago·Positive
Encompass Health Expands Rehab Footprint With New Maine Hospital EHC opens a 50-bed Maine rehab hospital, expanding its footprint as strong discharge growth and planned openings support capacity expansion.
View source ↗ - Newsprnewswire.com·47d ago·Neutral
Encompass Health Rehabilitation Hospital of Bangor now open in Maine BIRMINGHAM, Ala. and BANGOR, Maine, Oct. 6, 2026 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Bangor in Bangor, Maine.
View source ↗ - Newszacks.com·48d ago·Positive
Here's Why Encompass Health (EHC) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newsprnewswire.com·52d ago·Neutral
Encompass Health announces date of 2026 third-quarter earnings call BIRMINGHAM, Ala., Oct. 1, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept.
View source ↗ - Newszacks.com·58d ago·Neutral
Encompass Health Adds New Capacity With First Small-Format Hospital EHC is expanding near Houston with its first small-format rehab hospital and a 60-bed replacement facility in The Woodlands.
View source ↗ - News (RSS)investing·59d ago·Neutral
Encompass Health plans two hospitals in Montgomery County, Texas
View source ↗ - Newsprnewswire.com·59d ago·Neutral
Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital BIRMINGHAM, Ala., and CONROE, Texas, Sept.
View source ↗ - Newszacks.com·59d ago·Positive
Encompass Health (EHC) Upgraded to Buy: Here's Why Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newszacks.com·65d ago·Positive
Here's Why Encompass Health (EHC) is a Strong Growth Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - Newsprnewswire.com·68d ago·Neutral
Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania BIRMINGHAM, Ala. and EAGLEVILLE, Pa.
View source ↗ - News (RSS)yahoo·76d ago·Neutral
Encompass Health (EHC): This Rehab Hospital Giant Just Raised Its Own Bar Again
View source ↗ - News (RSS)seekingalpha·86d ago·Positive
Encompass Health Is Healthy Enough To Justify A Bullish View
View source ↗ - Newsseekingalpha.com·86d ago·Positive
… Corporation is the largest U.S. inpatient rehabilitation hospital operator, showing robust top- and bottom-line growth with industry-leading balance sheet strength. EHC is executing a disciplined expansion strategy, targeting 6–10 new hospitals and 80–120 bed additions annually, supported by favorable US demographic trends. Despite trading at a premium to peers, EHC's valuation remains attractive given its growth, profitability, and declining net leverage ratio.
View source ↗ - Newszacks.com·89d ago·Neutral
How EHC's Capacity Expansion Fuels a Multi-Year Growth Runway Encompass Health's capacity expansion, new facilities and North Carolina pipeline could fuel 6-8% multi-year discharge growth.
View source ↗ - Newszacks.com·89d ago·Positive
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - 4chan /biz/biz·89d ago·Neutral
Gemini's recommendation with my script Encompass Healthcare >mid cap >10% annual revenue growth >not levered >growing FCF >growing EPS >Doesn't print new shares >keeps reinvesting benefits into growing the business It is a as simple to ask a bot things that make a good business and you have a free stock screener. Just check the annual reports and stock price evolution to check for fishy stuff, but your free chatbot is a better financial advisor than 4chin
View source ↗ - Newszacks.com·93d ago·Neutral
Here's Why Encompass Health Can Be a Smart Addition to Your Portfolio EHC's rising demand, higher patient acuity and hospital expansion support growth, while rising expenses and debt remain key risks.
View source ↗ - Newszacks.com·95d ago·Positive
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - News (Marketaux)finance.yahoo.com·98d ago·Positive
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know Coltharp, EVP and chief financial office[+226 characters]
View source ↗ - News (RSS)fool·98d ago·Negative
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know This sale reduced an insider's direct common stock position by 27%, though a majority of the position remains held through trusts and spousal holdings.
View source ↗ - News (RSS)fool·98d ago·Neutral
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know Tarr reduced his direct equity stake but retains roughly 268,000 shares valued at $33.7 million.
View source ↗ - Newsfool.com·98d ago·Negative
What Three Encompass Health Insiders Selling Signals After a Rate Increase The transaction realized approximately $1.1 million at a weighted average price of $125.95 per share. The executive reduced his direct common stock holdings by 11% through this open-market sale.
View source ↗ - Newsfool.com·98d ago·Negative
Encompass Health's CFO Trimmed His Stake as Shares Jumped After Earnings. Here's What to Know Coltharp executed the sale of 18,869 shares at a weighted average price of $125.38 per share on August 10. The transaction reduced the executive's direct equity position by 27%, while his total beneficial ownership decreased by 7%.
View source ↗ - Newsfool.com·98d ago·Positive
Should You Worry That Encompass Health's CEO Sold Into a Rally? Here's What to Know The transaction involved 173,148 shares sold at a weighted average price of $125.47, totaling approximately $21.7 million. This disposition represents 39% of the CEO's direct common stock holdings in the company.
View source ↗ - News (RSS)investing.com·103d ago·Neutral
Encompass Health Named Top SMidCap Pick by TD Cowen
View source ↗ - Newsprnewswire.com·104d ago·Neutral
Encompass Health prices private offering of additional 5.875% senior notes due 2034 BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034 (the "Additional Notes") at a price of 98.75% of the principal amount thereof.
View source ↗ - News (RSS)seekingalpha·104d ago·Neutral
Encompass Health announces private offering of 5.875% senior notes
View source ↗ - Newsprnewswire.com·104d ago·Neutral
Encompass Health announces launch of private offering of 5.875% senior notes due 2034 BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5.875% senior notes maturing in 2034 (the "Additional Notes"), subject to market and other conditions.
View source ↗ - Newsmarketbeat.com·106d ago·Neutral
Encompass Health Q2 Earnings Call Highlights Encompass Health NYSE: EHC reported second-quarter 2026 results marked by revenue, earnings and discharge growth, prompting the inpatient rehabilitation provider to raise its full-year outlook.
View source ↗
Earnings
Thu, Feb 4(in 2 months)
Consensus estimate $1.60 per share
Typical surprise +11.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 28$1.52 vs $1.36beat
- Wed, Aug 5$1.55 vs $1.48beat
- Thu, Apr 30$1.60 vs $1.51beat
- Thu, Feb 5$1.46 vs $1.29beat
- Wed, Oct 29$1.23 vs $1.19beat
- Tue, Aug 5$1.40 vs $1.23beat
Estimates and results for EHC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by EHC officers and directors.
- Bought
- —
- Sold
- $30.7m
0 trades
10 trades
- Price Andrew Lsold
- Darby John Patricksold
- Coltharp Douglas Esold
- Tarr Mark Jsold
- Tarr Mark Jsold
- Darby John Patricksold
- Coltharp Douglas Esold
- Coltharp Douglas Esold
90 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Apr 7, 2023 (24d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jan 3, 2023 (28d later)Buy$1,001 - $15,000
- Peter Meijerhouse · MI03 · disclosed Mar 16, 2021 (28d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Oct 7, 2020 (41d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Jun 15, 2020 (27d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Aug 29, 2019 (29d later)Sell$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Apr 8, 2019 (24d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
